PADCEV subst sèche 20 mg flac
7680682910014
CH-68291
L01FX13
07.16.1.
1 / 3
google
Details
- Product number
- 6829103
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: enfortumabum vedotinum 20 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, polysorbatum 20, pro vitro.
Articles (1)
Padcev 20 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
enfortumabum vedotinum
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
histidinum
|
- | Substance | HNIDK |
|
histidini hydrochloridum monohydricum
|
- | Substance | HNIDK |
|
trehalosum dihydricum
|
- | Substance | HNIDK |
|
polysorbatum 20
|
- | Substance | HNIDK |
Authorization holder
Astellas Pharma AG
8304 Wallisellen
Authorization information
- Swissmedic authorization number
- 68291
- Drug name
- Padcev, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- L01FX13
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 09/11/2021
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PADCEV subst sèche 20 mg flac
- Description (DE)
- PADCEV Trockensub 20 mg Durchstf
- Market launch
- 09/11/2021
- Narcotic (BTM)
- No